Press "Enter" to skip to content

Panacea Biotec launches generic diabetes treatment drug in India

Vildagliptin product patent in India has expired on December 9, 2019 , the company said.

Original source: https://health.economictimes.indiatimes.com/news/pharma/panacea-biotec-launches-generic-diabetes-treatment-drug-in-india/72455614?utm_source=RSS&utm_medium=ETRSS

Also Read:   Insys to pay $225 million, plead guilty in U.S. over opioid kickbacks